Response to letter to the editor. Again on IMPACT: exacerbation after abrupt discontinuation of ICS and pneumonia in fluticasone furoate-containing FDCs / Rogliani, P.; Calzetta, L.. - In: EXPERT OPINION ON PHARMACOTHERAPY. - ISSN 1465-6566. - 22:7(2021), pp. 943-945. [10.1080/14656566.2021.1898746]

Response to letter to the editor. Again on IMPACT: exacerbation after abrupt discontinuation of ICS and pneumonia in fluticasone furoate-containing FDCs

Calzetta L.
2021-01-01

2021
Response to letter to the editor. Again on IMPACT: exacerbation after abrupt discontinuation of ICS and pneumonia in fluticasone furoate-containing FDCs / Rogliani, P.; Calzetta, L.. - In: EXPERT OPINION ON PHARMACOTHERAPY. - ISSN 1465-6566. - 22:7(2021), pp. 943-945. [10.1080/14656566.2021.1898746]
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11381/2903421
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 0
  • ???jsp.display-item.citation.isi??? 0
social impact